Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
Authors:
- Jakub AdamskiJAJakub Adamski
- Brian GodmanBGBrian Godman
- Gabriella Ofierska-SujkowskaGOGabriella Ofierska-Sujkowska
- Bogusława OsińskaBOBogusława Osińska
- Harald HerholzHHHarald Herholz
- Kamila WendykowskaKWKamila Wendykowska
- Ott LaiusOLOtt Laius
- Saira JanSJSaira Jan
- Catherine SermetCSCatherine Sermet
- Corrine ZaraCZCorrine Zara
- Marija KalabaMKMarija Kalaba
- Roland GustafssonRGRoland Gustafsson
Open Access
- 7 June 2010
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 10 (1) , 153
Abstract
There has been an increase in 'risk sharing' schemes for pharmaceuticals between healthcare institutions and pharmaceutical companies in Europe in recent years as an additional approach to provide continued comprehensive and equitable healthcare. There is though confusion surrounding the terminology as well as concerns with existing schemes.Keywords
This publication has 54 references indexed in Scilit:
- Canʼt Get No Satisfaction? Will Pay for Performance Help?PharmacoEconomics, 2010
- Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevanceExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Market and patient access to new oncology products in Europe: a current, multidisciplinary perspectiveAnnals of Oncology, 2008
- Insight into recent reforms and initiatives in Austria: implications for key stakeholdersExpert Review of Pharmacoeconomics & Outcomes Research, 2008
- Balancing Big Pharma’s booksBMJ, 2008
- Value based pricing for NHS drugs: an opportunity not to be missed?BMJ, 2008
- The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a reviewInternational Journal Of Clinical Practice, 2007
- How can we regulate medicines better?BMJ, 2007
- Pharmaceutical policies: effects of financial incentives for prescribers2007
- How much will Herceptin really cost?BMJ, 2006